Press Releases Aequus Pharmaceuticals Inc.

Equities

AQS

CA0076361033

Delayed Toronto S.E. Other stock markets 01:49:21 2024-07-08 pm EDT			5-day change	1st Jan Change
0.025 ^CAD	-16.67%		-16.67%	0.00%

Jul. 03	Aequus Pharmaceuticals Inc. Signs Exclusive Distribution Agreement with Advanced Ophthalmic Innovations for the Paul® Glaucoma Drainage Device in Canada	CI
May. 10	Aequus Pharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Aequus Provides Launch Update Zimed PF	Jul. 03	AQ
Aequus Signs Exclusive Distribution Agreement with Advanced Ophthalmic Innovations for the PAUL Glaucoma Drainage Device in Canada	May. 22	AQ
Aequus Provides General Update and First Quarter 2024 Financial Highlights, Grant Stock Options and Financing	May. 09	AQ
Aequus Poised to Fill Bimatoprost 0.03% Drug Shortage in Canada	May. 07	AQ
Aequus Provides General Update and Fiscal 2023 Financial Results	Apr. 29	AQ
Aequus Reports Third Quarter 2023 Financial Highlights and General Update	Nov. 29	AQ
Aequus Announces New Financing	23-10-20	AQ
Aequus Announces New Financing and Provides Launch Update of Zimed Preservative Free (Bimatoprost 0.03%)	23-10-06	AQ
Aequus Reports Second Quarter 2023 Financial Highlights and General Update	23-08-29	GL
Aequus Announces Zimed PF Now Available in Canada	23-08-24	GL
Aequus Announces Zimed PF Website Launch	23-08-22	GL
Aequus Pharmaceutical Canada Announces a Pause in Sales of Evolve Intensive Eyedrops and Gel in Canada	23-08-21	AQ
Aequus Pharmaceutical Canada Announces a Pause in Sales of Evolve Intensive Eyedrops and Gel in Canada	23-08-18	GL
Aequus Pharmaceutical Canada Announces a Pause in Sales of Evolve Intensive Eyedrops and Gel in Canada	23-08-18	AQ
Aequus Announces Financing to Support Launch of Zimed Preservative Free	23-07-07	AQ
Aequus Announces Financing to Support Launch of Zimed Preservative Free (Bimatoprost 0.03%)	23-07-06	GL
Aequus Provides General Update and First Quarter 2023 Financial Highlights	23-05-30	GL
Aequus Provides General Update and Fiscal 2022 Financial Results	23-05-01	GL
Aequus Grants Stock Options	23-04-19	GL
Aequus Grants Stock Options	23-04-19	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Aequus Pharmaceuticals Inc.

Equities

AQS

CA0076361033

Press Releases

Filters